2023 Regular Session • Alabama Legislature
HB433
Legislative Summary
Relating to Opioid Addiction Treatment; to repeal the Medication Assisted Treatment of Opioid Use Act of 2019, codified as Sections 20-2-300 through 20-2-302, Code of Alabama 1975, that provide for adoption of rules governing use of buprenorphine in the treatment of opioid addiction and a standing working group to assist in drafting the rules.
Demographic Impact
Overall analysis of equity impact
60% Bias
High ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
5/3/2023
Read First Time in House of Origin
House of Representatives
5/3/2023
Introduced and Referred to House Health
House of Representatives
5/10/2023
Reported Favorably from House Health
House of Representatives
5/10/2023
Reported Out of Committee in House of Origin
House of Representatives
5/11/2023
Read Second Time in House of Origin
House of Representatives
5/18/2023
On Third Reading in House of Origin
House of Representatives
5/18/2023
Substitute a Companion Bill
House of Representatives
5/31/2023
Indefinitely Postpone
House of Representatives
Status Information
Current Status
Introduced(5/3/2023)
Chamber
House of Representatives
Sine DiePrior Session
Sponsors
Republican: 1
Primary Sponsor
Frances Holk-Jones
Republican